# Neuphoria (NEUP) — Overview

NEUP · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/neup

## Price

Last close $3.31 on Oct 15, 2026. 52-week range $3.24 – $17.24.

## Company profile

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company focused on therapies for serious central nervous system disorders. Its lead product candidate, BNC210, is an oral, proprietary, selective negative allosteric modulator of the alpha7 nicotinic acetylcholine receptor. The company has discontinued development of BNC210 for social anxiety disorder, while its BNC210 program for post-traumatic stress disorder is currently paused and no active clinical trial is underway. The company operates through a single operating and reporting segment focused on the discovery and development of allosteric ion-channel modulators for serious CNS disorders with high unmet medical need.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $1.2M |
| Revenue (quarter) | $1.2M |
| Revenue growth (year over year) | 8950.27% |
| Gross profit (trailing twelve months) | $1.2M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$13.5M |
| Net income (quarter) | −$4.9M |
| Net income growth (year over year) | 44.79% |
| Net margin | -1145.66% |
| Return on equity | -61.70% |
| EPS (trailing twelve months) | −$3.06 |
| Book value per share | $4.55 |
| P/E (trailing twelve months) | — |
| Price to book | 0.7 |
| Debt to assets | 14.31% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Neuphoria (NEUP) profitable?

No. Neuphoria reported a net loss of $13.5M over the trailing twelve months.

### How much revenue does Neuphoria (NEUP) make?

Neuphoria generated $1.2M in revenue over the trailing twelve months, up 8950.27% year over year.

### How do I buy stock in Neuphoria (NEUP)?

NEUP trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).